Global HIV Therapeutics Market Research Report 2022

SKU ID : QYR-21348553 | Publishing Date : 18-Jul-2022 | No. of pages : 86

Detailed TOC of Global HIV Therapeutics Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global HIV Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
        1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
        1.2.4 Entry and Fusion Inhibitors
        1.2.5 Protease Inhibitors (PIs)
        1.2.6 Integrase Inhibitors
        1.2.7 Coreceptor Antagonists
    1.3 Market by Application
        1.3.1 Global HIV Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Labs
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global HIV Therapeutics Market Perspective (2017-2028)
    2.2 HIV Therapeutics Growth Trends by Region
        2.2.1 HIV Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 HIV Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 HIV Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 HIV Therapeutics Market Dynamics
        2.3.1 HIV Therapeutics Industry Trends
        2.3.2 HIV Therapeutics Market Drivers
        2.3.3 HIV Therapeutics Market Challenges
        2.3.4 HIV Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top HIV Therapeutics Players by Revenue
        3.1.1 Global Top HIV Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global HIV Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global HIV Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by HIV Therapeutics Revenue
    3.4 Global HIV Therapeutics Market Concentration Ratio
        3.4.1 Global HIV Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by HIV Therapeutics Revenue in 2021
    3.5 HIV Therapeutics Key Players Head office and Area Served
    3.6 Key Players HIV Therapeutics Product Solution and Service
    3.7 Date of Enter into HIV Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Therapeutics Breakdown Data by Type
    4.1 Global HIV Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global HIV Therapeutics Forecasted Market Size by Type (2023-2028)
5 HIV Therapeutics Breakdown Data by Application
    5.1 Global HIV Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global HIV Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America HIV Therapeutics Market Size (2017-2028)
    6.2 North America HIV Therapeutics Market Size by Country (2017-2022)
    6.3 North America HIV Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe HIV Therapeutics Market Size (2017-2028)
    7.2 Europe HIV Therapeutics Market Size by Country (2017-2022)
    7.3 Europe HIV Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific HIV Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific HIV Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific HIV Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America HIV Therapeutics Market Size (2017-2028)
    9.2 Latin America HIV Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America HIV Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa HIV Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa HIV Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa HIV Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Boehringer Ingelheim International GmbH
        11.1.1 Boehringer Ingelheim International GmbH Company Detail
        11.1.2 Boehringer Ingelheim International GmbH Business Overview
        11.1.3 Boehringer Ingelheim International GmbH HIV Therapeutics Introduction
        11.1.4 Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2017-2022)
        11.1.5 Boehringer Ingelheim International GmbH Recent Development
    11.2 Merck & Co.
        11.2.1 Merck & Co. Company Detail
        11.2.2 Merck & Co. Business Overview
        11.2.3 Merck & Co. HIV Therapeutics Introduction
        11.2.4 Merck & Co. Revenue in HIV Therapeutics Business (2017-2022)
        11.2.5 Merck & Co. Recent Development
    11.3 ViiV Healthcare
        11.3.1 ViiV Healthcare Company Detail
        11.3.2 ViiV Healthcare Business Overview
        11.3.3 ViiV Healthcare HIV Therapeutics Introduction
        11.3.4 ViiV Healthcare Revenue in HIV Therapeutics Business (2017-2022)
        11.3.5 ViiV Healthcare Recent Development
    11.4 AbbVie
        11.4.1 AbbVie Company Detail
        11.4.2 AbbVie Business Overview
        11.4.3 AbbVie HIV Therapeutics Introduction
        11.4.4 AbbVie Revenue in HIV Therapeutics Business (2017-2022)
        11.4.5 AbbVie Recent Development
    11.5 F. Hoffmann-La Roche Ltd.
        11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
        11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
        11.5.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Introduction
        11.5.4 F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2017-2022)
        11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
    11.6 Teva Pharmaceutical Industries Ltd.
        11.6.1 Teva Pharmaceutical Industries Ltd. Company Detail
        11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
        11.6.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Introduction
        11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2017-2022)
        11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
    11.7 Bristol-Myers Squibb
        11.7.1 Bristol-Myers Squibb Company Detail
        11.7.2 Bristol-Myers Squibb Business Overview
        11.7.3 Bristol-Myers Squibb HIV Therapeutics Introduction
        11.7.4 Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2017-2022)
        11.7.5 Bristol-Myers Squibb Recent Development
    11.8 Gilead Sciences
        11.8.1 Gilead Sciences Company Detail
        11.8.2 Gilead Sciences Business Overview
        11.8.3 Gilead Sciences HIV Therapeutics Introduction
        11.8.4 Gilead Sciences Revenue in HIV Therapeutics Business (2017-2022)
        11.8.5 Gilead Sciences Recent Development
    11.9 Johnson & Johnson
        11.9.1 Johnson & Johnson Company Detail
        11.9.2 Johnson & Johnson Business Overview
        11.9.3 Johnson & Johnson HIV Therapeutics Introduction
        11.9.4 Johnson & Johnson Revenue in HIV Therapeutics Business (2017-2022)
        11.9.5 Johnson & Johnson Recent Development
    11.10 Cipla Limited
        11.10.1 Cipla Limited Company Detail
        11.10.2 Cipla Limited Business Overview
        11.10.3 Cipla Limited HIV Therapeutics Introduction
        11.10.4 Cipla Limited Revenue in HIV Therapeutics Business (2017-2022)
        11.10.5 Cipla Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global HIV Therapeutics Market Research Report 2022

List of Tables
    Table 1. Global HIV Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
    Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Table 4. Key Players of Entry and Fusion Inhibitors
    Table 5. Key Players of Protease Inhibitors (PIs)
    Table 6. Key Players of Integrase Inhibitors
    Table 7. Key Players of Coreceptor Antagonists
    Table 8. Global HIV Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global HIV Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global HIV Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global HIV Therapeutics Market Share by Region (2017-2022)
    Table 12. Global HIV Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global HIV Therapeutics Market Share by Region (2023-2028)
    Table 14. HIV Therapeutics Market Trends
    Table 15. HIV Therapeutics Market Drivers
    Table 16. HIV Therapeutics Market Challenges
    Table 17. HIV Therapeutics Market Restraints
    Table 18. Global HIV Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global HIV Therapeutics Market Share by Players (2017-2022)
    Table 20. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2021)
    Table 21. Ranking of Global Top HIV Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by HIV Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players HIV Therapeutics Product Solution and Service
    Table 25. Date of Enter into HIV Therapeutics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global HIV Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global HIV Therapeutics Revenue Market Share by Type (2017-2022)
    Table 29. Global HIV Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global HIV Therapeutics Revenue Market Share by Type (2023-2028)
    Table 31. Global HIV Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global HIV Therapeutics Revenue Market Share by Application (2017-2022)
    Table 33. Global HIV Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global HIV Therapeutics Revenue Market Share by Application (2023-2028)
    Table 35. North America HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific HIV Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific HIV Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa HIV Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa HIV Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Boehringer Ingelheim International GmbH Company Detail
    Table 46. Boehringer Ingelheim International GmbH Business Overview
    Table 47. Boehringer Ingelheim International GmbH HIV Therapeutics Product
    Table 48. Boehringer Ingelheim International GmbH Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Boehringer Ingelheim International GmbH Recent Development
    Table 50. Merck & Co. Company Detail
    Table 51. Merck & Co. Business Overview
    Table 52. Merck & Co. HIV Therapeutics Product
    Table 53. Merck & Co. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Merck & Co. Recent Development
    Table 55. ViiV Healthcare Company Detail
    Table 56. ViiV Healthcare Business Overview
    Table 57. ViiV Healthcare HIV Therapeutics Product
    Table 58. ViiV Healthcare Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. ViiV Healthcare Recent Development
    Table 60. AbbVie Company Detail
    Table 61. AbbVie Business Overview
    Table 62. AbbVie HIV Therapeutics Product
    Table 63. AbbVie Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. AbbVie Recent Development
    Table 65. F. Hoffmann-La Roche Ltd. Company Detail
    Table 66. F. Hoffmann-La Roche Ltd. Business Overview
    Table 67. F. Hoffmann-La Roche Ltd. HIV Therapeutics Product
    Table 68. F. Hoffmann-La Roche Ltd. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. F. Hoffmann-La Roche Ltd. Recent Development
    Table 70. Teva Pharmaceutical Industries Ltd. Company Detail
    Table 71. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 72. Teva Pharmaceutical Industries Ltd. HIV Therapeutics Product
    Table 73. Teva Pharmaceutical Industries Ltd. Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 74. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 75. Bristol-Myers Squibb Company Detail
    Table 76. Bristol-Myers Squibb Business Overview
    Table 77. Bristol-Myers Squibb HIV Therapeutics Product
    Table 78. Bristol-Myers Squibb Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 79. Bristol-Myers Squibb Recent Development
    Table 80. Gilead Sciences Company Detail
    Table 81. Gilead Sciences Business Overview
    Table 82. Gilead Sciences HIV Therapeutics Product
    Table 83. Gilead Sciences Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 84. Gilead Sciences Recent Development
    Table 85. Johnson & Johnson Company Detail
    Table 86. Johnson & Johnson Business Overview
    Table 87. Johnson & Johnson HIV Therapeutics Product
    Table 88. Johnson & Johnson Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 89. Johnson & Johnson Recent Development
    Table 90. Cipla Limited Company Detail
    Table 91. Cipla Limited Business Overview
    Table 92. Cipla Limited HIV Therapeutics Product
    Table 93. Cipla Limited Revenue in HIV Therapeutics Business (2017-2022) & (US$ Million)
    Table 94. Cipla Limited Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HIV Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features
    Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
    Figure 4. Entry and Fusion Inhibitors Features
    Figure 5. Protease Inhibitors (PIs) Features
    Figure 6. Integrase Inhibitors Features
    Figure 7. Coreceptor Antagonists Features
    Figure 8. Global HIV Therapeutics Market Share by Application in 2021 & 2028
    Figure 9. Hospitals Case Studies
    Figure 10. Clinics Case Studies
    Figure 11. Labs Case Studies
    Figure 12. HIV Therapeutics Report Years Considered
    Figure 13. Global HIV Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global HIV Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global HIV Therapeutics Market Share by Region: 2021 VS 2028
    Figure 16. Global HIV Therapeutics Market Share by Players in 2021
    Figure 17. Global Top HIV Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapeutics as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by HIV Therapeutics Revenue in 2021
    Figure 19. North America HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America HIV Therapeutics Market Share by Country (2017-2028)
    Figure 21. United States HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe HIV Therapeutics Market Share by Country (2017-2028)
    Figure 25. Germany HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific HIV Therapeutics Market Share by Region (2017-2028)
    Figure 33. China HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America HIV Therapeutics Market Share by Country (2017-2028)
    Figure 41. Mexico HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa HIV Therapeutics Market Share by Country (2017-2028)
    Figure 45. Turkey HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia HIV Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Boehringer Ingelheim International GmbH Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 48. Merck & Co. Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 49. ViiV Healthcare Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 50. AbbVie Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 51. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 53. Bristol-Myers Squibb Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 54. Gilead Sciences Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 55. Johnson & Johnson Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 56. Cipla Limited Revenue Growth Rate in HIV Therapeutics Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed

Keyplayers in Global HIV Therapeutics Market Research Report 2022

Boehringer Ingelheim International GmbH
Merck & Co.
ViiV Healthcare
AbbVie
F. Hoffmann-La Roche Ltd.
Teva Pharmaceutical Industries Ltd.
Bristol-Myers Squibb
Gilead Sciences
Johnson & Johnson
Cipla Limited